Clinical Trials List
2016-01-06 - 2018-12-31
Phase II
Terminated2
ICD-10C22.1
Intrahepatic bile duct carcinoma
-
Trial Applicant
ASLAN PHARMACEUTICALS TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Taiwan National PI
Co-Principal Investigator
- Ming-Huang Chen Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
- Rheun-Chuan Lee Division of Pediatrics
The Actual Total Number of Participants Enrolled
1 Terminated
Audit
None
Co-Principal Investigator
- Nai-Jung Chiang Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
- 姜乃榕 Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
25 participants
